Showing results (1181-1190 of 6,326) with videos related to

Sort By:
Pageof 633
Diabetes, Obesity & Metabolism|December 9, 2024
Identifying subgroups benefiting from intensive glycaemic treatment to improve renal outcomes in type 2 diabetes: Insights from the ACCORD trialYiqin Wang, Qiong Wen, Yuewen Lu, et al.
Diabetes, Obesity & Metabolism|September 4, 2024
Causal relationship between key genes and metabolic dysfunction-associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysisGong Feng, Na He, Jing Gao, et al.
Diabetes, Obesity & Metabolism|September 6, 2024
Association of N-terminal pro-B natriuretic peptide with all-cause mortality and cardiovascular mortality in obese and non-obese populations and the development of a machine learning prediction model: National Health and Nutrition Examination Survey (NHANES) 1999-2004Han Zhou, Chen Yang, Jingjie Li, et al.
Diabetes, Obesity & Metabolism|September 6, 2024
Evaluating remission of type 2 diabetes using a metabolic intervention including fixed-ratio insulin degludec and liraglutide: A randomized controlled trialZubin Punthakee, Stephanie Hall, Natalia McInnes, et al.
Diabetes, Obesity & Metabolism|August 31, 2024
Patient-reported outcomes in studies of diabetes technology: What mattersAlexandros L Liarakos, Thomas S J Crabtree, Emma G Wilmot
Diabetes, Obesity & Metabolism|August 19, 2024
Interventions to improve glycaemic control in people living with, and at risk of developing type 2 diabetesNerys M Astbury
Diabetes, Obesity & Metabolism|August 19, 2024
Variations in healthcare costs by body mass index and obesity-related complications in a UK population: A retrospective open cohort studyJonathan Pearson-Stuttard, Sara Holloway, Kasper Sommer Matthiessen, et al.
Diabetes, Obesity & Metabolism|August 19, 2024
Opportunities to optimize lifestyle interventions in combination with glucagon-like peptide-1-based therapySatya Dash
Diabetes, Obesity & Metabolism|August 31, 2024
Adherence to glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes mellitus: A nationwide registry studyMats C H Lassen, Niklas Dyrby Johansen, Daniel Modin, et al.
Diabetes, Obesity & Metabolism|August 28, 2024
Reduced insulin clearance in paediatric metabolic (dysfunction)-associated fatty liver disease and its dual role in beta-cell offload and diabetes riskLi Jiang, Jinxin Lai, Xu Xu, et al.
Pageof 633